A real-world comparison of vernakalant efficacy and safety for pharmacological cardioversion in patients with recent-onset atrial fibrillation in an emergency department and after cardiac surgery.
18 June 2017 (08:30 - 18:00)
Organised by:
Abstract
About the speaker
University Hospital La Fe, Valencia (Spain)
6 More presentations in this session
Access the full session
The Event
EHRA EUROPACE - CARDIOSTIM 2017
18 June 2017
08:30 CET